BlastAssist:一种测量人类胚胎可解释特征的深度学习流程
BlastAssist深度学习流程整合五个网络,测量人类胚胎可解释特征。在67 043 973张图像(32 939个胚胎)上与专家和胚胎学家比较,多数指标表现相当或更优。该流程输出可解释的定量测量,有助于临床决策。
要点
- BlastAssist整合五个深度学习网络,测量受精状态、对称性、碎片程度和发育时序等特征。
- 受精状态AUROC 0.84-0.94,发育时序准确率90.0%与专家91.4%相当。
- 2细胞时间与2细胞对称性与植入成功率显著相关(P<0.01和P<0.03)。
核心结论
- BlastAssist流程能全面测量人类胚胎可解释特征,在多项指标上表现与胚胎学家和人类专家相当或更优。
- 该流程输出有意义的胚胎测量值,可被胚胎学家解释和验证,对临床决策至关重要。
研究设计与样本
- 应用BlastAssist流程分析2012至2017年Tel Aviv Sourasky Medical Center IVF实验室记录的67 043 973张图像(32 939个胚胎)。
- 将流程测量与人类专家手动测量比较:受精状态(n=207胚胎)、细胞对称性(n=109胚胎)、碎片程度(n=6664图像)、发育时序(n=21 036图像)。
- 与胚胎学家常规治疗中的标注比较:受精状态(n=18 922胚胎)、原核消失时间(n=13 781胚胎)、第2天碎片程度(n=11 582胚胎)、囊胚形成时间(n=3266胚胎)。
- 与723个单胚胎移植周期的植入结果及1801个周期中3421个移植胚胎的活产结果比较。
- 使用Pearson χ2检验评估个体特征与植入成功的统计独立性,贝叶斯统计评估胚胎活产概率与BlastAssist输入的关联。
主要发现
- 受精状态网络特异性和敏感性参数良好(AUROC 0.84-0.94)。
- 对称性评分在2细胞期(r=0.71±0.06)和4细胞期(r=0.77±0.07)与人类专家表现相当。
- 碎片程度流程准确率69.4%略低于人类专家73.8%;发育时序流程准确率90.0%与人类专家91.4%相似。
- 流程与胚胎学家标注强一致:受精状态准确率79.6%(r=0.683),碎片程度准确率55.4%(r=0.648),原核消失时间r=0.787,囊胚形成时间r=0.887。
- 单胚胎移植周期中,2细胞时间(P<0.01)和2细胞对称性(P<0.03)与植入成功率显著相关;2细胞时间(P<5×10-11)、原核消失时间(P<5×10-10)、第3天碎片程度(P<5×10-4)和2细胞对称性(P<5×10-3)与移植胚胎活产概率显著相关。
关键数值与推荐
- 受精状态AUROC 0.84-0.94。
- 对称性评分2细胞期r=0.71±0.06,4细胞期r=0.77±0.07。
- 碎片程度准确率:流程69.4% vs 人类专家73.8%。
- 发育时序准确率:流程90.0% vs 人类专家91.4%。
- 流程与胚胎学家比较:受精状态准确率79.6%(r=0.683),碎片程度准确率55.4%(r=0.648),原核消失时间r=0.787,囊胚形成时间r=0.887。
临床怎么用
- BlastAssist提供全面整体的胚胎评估方法,输出可解释的测量值供胚胎学家验证。
- 该流程生成的大规模数据集可作为人类胚胎学和IVF进一步研究的资源。
- 原文未据此给出临床推荐。
局限性
- 未在其他诊所或其他延时显微成像系统的数据上测试BlastAssist流程。
- 与活产结果的关联研究未考虑混杂变量,构建胚胎选择算法时需要纳入。
- 需要随机对照试验确定该流程能否提高临床IVF成功率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can the BlastAssist deep learning pipeline perform comparably to or outperform human experts and embryologists at measuring interpretable, clinically relevant features of human embryos in IVF? SUMMARY ANSWER: The BlastAssist pipeline can measure a comprehensive set of interpretable features of human embryos and either outperform or perform comparably to embryologists and human experts in measuring these features. WHAT IS KNOWN ALREADY: Some studies have applied deep learning and developed 'black-box' algorithms to predict embryo viability directly from microscope images and videos but these lack interpretability and generalizability. Other studies have developed deep learning networks to measure individual features of embryos but fail to conduct careful comparisons to embryologists' performance, which are fundamental to demonstrate the network's effectiveness. STUDY DESIGN, SIZE, DURATION: We applied the BlastAssist pipeline to 67 043 973 images (32 939 embryos) recorded in the IVF lab from 2012 to 2017 in Tel Aviv Sourasky Medical Center. We first compared the pipeline measurements of individual images/embryos to manual measurements by human experts for sets of features, including: (i) fertilization status (n = 207 embryos), (ii) cell symmetry (n = 109 embryos), (iii) degree of fragmentation (n = 6664 images), and (iv) developmental timing (n = 21 036 images). We then conducted detailed comparisons between pipeline outputs and annotations made by embryologists during routine treatments for features, including: (i) fertilization status (n = 18 922 embryos), (ii) pronuclei (PN) fade time (n = 13 781 embryos), (iii) degree of fragmentation on Day 2 (n = 11 582 embryos), and (iv) time of blastulation (n = 3266 embryos). In addition, we compared the pipeline outputs to the implantation results of 723 single embryo transfer (SET) cycles, and to the live birth results of 3421 embryos transferred in 1801 cycles. PARTICIPANTS/MATERIALS, SETTING, METHODS: In addition to EmbryoScope™ image data, manual embryo grading and annotations, and electronic health record (EHR) data on treatment outcomes were also included. We integrated the deep learning networks we developed for individual features to construct the BlastAssist pipeline. Pearson's χ2 test was used to evaluate the statistical independence of individual features and implantation success. Bayesian statistics was used to evaluate the association of the probability of an embryo resulting in live birth to BlastAssist inputs. MAIN RESULTS AND THE ROLE OF CHANCE: The BlastAssist pipeline integrates five deep learning networks and measures comprehensive, interpretable, and quantitative features in clinical IVF. The pipeline performs similarly or better than manual measurements. For fertilization status, the network performs with very good parameters of specificity and sensitivity (area under the receiver operating characteristics (AUROC) 0.84-0.94). For symmetry score, the pipeline performs comparably to the human expert at both 2-cell (r = 0.71 ± 0.06) and 4-cell stages (r = 0.77 ± 0.07). For degree of fragmentation, the pipeline (acc = 69.4%) slightly under-performs compared to human experts (acc = 73.8%). For developmental timing, the pipeline (acc = 90.0%) performs similarly to human experts (acc = 91.4%). There is also strong agreement between pipeline outputs and annotations made by embryologists during routine treatments. For fertilization status, the pipeline and embryologists strongly agree (acc = 79.6%), and there is strong correlation between the two measurements (r = 0.683). For degree of fragmentation, the pipeline and embryologists mostly agree (acc = 55.4%), and there is also strong correlation between the two measurements (r = 0.648). For both PN fade time (r = 0.787) and time of blastulation (r = 0.887), there's strong correlation between the pipeline and embryologists. For SET cycles, 2-cell time (P < 0.01) and 2-cell symmetry (P < 0.03) are significantly correlated with implantation success rate, while other features showed correlations with implantation success without statistical significance. In addition, 2-cell time (P < 5 × 10-11), PN fade time (P < 5 × 10-10), degree of fragmentation on Day 3 (P < 5 × 10-4), and 2-cell symmetry (P < 5 × 10-3) showed statistically significant correlation with the probability of the transferred embryo resulting in live birth. LIMITATIONS, REASONS FOR CAUTION: We have not tested the BlastAssist pipeline on data from other clinics or other time-lapse microscopy (TLM) systems. The association study we conducted with live birth results do not take into account confounding variables, which will be necessary to construct an embryo selection algorithm. Randomized controlled trials (RCT) will be necessary to determine whether the pipeline can improve success rates in clinical IVF. WIDER IMPLICATIONS OF THE FINDINGS: BlastAssist provides a comprehensive and holistic means of evaluating human embryos. Instead of using a black-box algorithm, BlastAssist outputs meaningful measurements of embryos that can be interpreted and corroborated by embryologists, which is crucial in clinical decision making. Furthermore, the unprecedentedly large dataset generated by BlastAssist measurements can be used as a powerful resource for further research in human embryology and IVF. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by Harvard Quantitative Biology Initiative, the NSF-Simons Center for Mathematical and Statistical Analysis of Biology at Harvard (award number 1764269), the National Institute of Heath (award number R01HD104969), the Perelson Fund, and the Sagol fund for embryos and stem cells as part of the Sagol Network. The authors declare no competing interests. TRIAL REGISTRATION NUMBER: Not applicable.
引用
- Yang HY, Leahy BD, Jang WD, et al. BlastAssist: a deep learning pipeline to measure interpretable features of human embryos. Hum Reprod. 2024. PMID: 38396213. doi:10.1093/humrep/deae024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。